Table 4.

Partial correlation analyses for the associations between TMAO-related metabolites and lipids after rosuvastatin therapy (n = 112)

Variables	TMAO		Choline		Carnitine		Betaine		GBB
	r	P	r	P	r	P	r	P	r	P
TG	0.076	0.434	0.051	0.598	0.003	0.978	−0.202	0.035	−0.143	0.139
TC	−0.158	0.101	0.020	0.833	−0.104	0.281	−0.092	0.341	0.177	0.065
HDL-c	−0.172	0.074	0.046	0.633	0.052	0.591	0.088	0.361	0.063	0.513
LDL-c	−0.171	0.075	−0.071	0.460	−0.298	0.002	− 0.175	0.069	0.012	0.903
ApoA1	−0.059	0.539	0.035	0.716	−0.026	0.785	0.020	0.840	0.018	0.854
ApoB	−0.122	0.205	−0.075	0.440	−0.255	0.007	−0.150	0.119	−0.068	0.484

TMAO Trimethylamine N-oxide, TG Triglycerides, TC Total cholesterol, HDL-c High-density lipoprotein cholesterol, LDL-c Low-density lipoprotein cholesterol, ApoA1 Apolipoprotein A1, ApoB Apolipoprotein B, GBB γ-butyrobetaine. Partial correlation was performed by controlling for sex, age, body mass index and estimated glomerular filtration rate.